{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:46:06Z","timestamp":1792464366082,"version":"4.5.0"},"reference-count":165,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00397","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:43:01Z","timestamp":1586911381000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":316,"title":["Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression"],"prefix":"10.3389","volume":"10","author":[{"given":"Sylvie","family":"Brassart-Pasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Br\u00e9zillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Brassart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Ramont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Oudart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claude","family":"Monboisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat Rev Cancer."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1158\/0008-5472.CAN-10-2583","article-title":"Tumor-associated neutrophils: new targets for cancer therapy","volume":"71","author":"Gregory","year":"2011","journal-title":"Cancer Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat Rev Cancer."},{"key":"B5","doi-asserted-by":"publisher","first-page":"52575","DOI":"10.18632\/oncotarget.9824","article-title":"Targeting microenvironment in cancer therapeutics","volume":"7","author":"Martin","year":"2016","journal-title":"Oncotarget."},{"key":"B6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccr.2005.05.024","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"7","author":"Joyce","year":"2005","journal-title":"Cancer Cell."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1700167","DOI":"10.1002\/pmic.201700167","article-title":"Cancer associated fibroblasts: the architects of stroma remodeling","volume":"18","author":"Santi","year":"2018","journal-title":"Proteomics."},{"key":"B8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fonc.2013.00154","article-title":"The tumor microenvironment and strategies to improve drug distribution","volume":"3","author":"Saggar","year":"2013","journal-title":"Front Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fonc.2018.00189","article-title":"Hypoxic signalling in tumour stroma","volume":"8","author":"Laitala","year":"2018","journal-title":"Front Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3389\/fonc.2019.01373","article-title":"mTORC1 as regulator of mitochondrial functions and a therapeutic target in cancer","volume":"9","author":"Griselda de la Cruz Lopezi","year":"2019","journal-title":"Front Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.canlet.2014.03.034","article-title":"Metabolic adaptation to cancer growth: From the cell to the organism","volume":"356","author":"Escot\u00e9","year":"2015","journal-title":"Cancer Lett."},{"key":"B12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.tcb.2017.06.003","article-title":"Metabolic interactions in the tumor microenvironment","volume":"27","author":"Lyssiotis","year":"2017","journal-title":"Trends Cell Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0304-4165(88)90147-X","article-title":"Collagen degradation by superoxide anion in pulse and gamma radiolysis","volume":"965","author":"Monboisse","year":"1988","journal-title":"BBA Gen Subj."},{"key":"B14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.semcdb.2018.06.005","article-title":"The cancer matrisome: From comprehensive characterization to biomarker discovery","volume":"89","author":"Socovich","year":"2019","journal-title":"Semin Cell Dev Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/labinvest.2013.132","article-title":"Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion","volume":"94","author":"Grahovac","year":"2014","journal-title":"Lab Investig."},{"key":"B16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.csbj.2018.07.003","article-title":"Biophysics of tumor microenvironment and cancer metastasis - a mini review","volume":"16","author":"Emon","year":"2018","journal-title":"Comput Struct Biotechnol J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10585-019-09966-1","article-title":"The extracellular matrix in tumor progression and metastasis","volume":"36","author":"Eble","year":"2019","journal-title":"Clin Exp Metastasis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1242\/jcs.116392","article-title":"The tumor microenvironment at a glance","volume":"125","author":"Balkwill","year":"2012","journal-title":"J Cell Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell."},{"key":"B20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1074\/jbc.M103466200","article-title":"Procollagen II amino propeptide processing by ADAMTS-3","volume":"120","author":"Fernandes","year":"2001","journal-title":"J Biol Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"20806","DOI":"10.1074\/jbc.M110.118521","article-title":"Type IIB procollagen NH2-propeptide induces death of tumor cells via interaction with integrins \u03b1v\u03b23 and \u03b1v\u03b25","volume":"285","author":"Wang","year":"2010","journal-title":"J Biol Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3109\/03008207.2013.867340","article-title":"Novel functions for Type II procollagen","volume":"55","author":"Sandell","year":"2014","journal-title":"Connect Tissue Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1292\/jvms.18-0674","article-title":"Cathepsin S degrades arresten and canstatin in infarcted area after myocardial infarction in rats","volume":"103","author":"Sugiyama","year":"2019","journal-title":"J Vet Med Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.devcel.2009.07.016","article-title":"MT2-MMP-dependent release of collagen IV NC1 domains regulates submandibular gland branching morphogenesis","volume":"40","author":"Rebustini","year":"2009","journal-title":"Dev Cell."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e51044","DOI":"10.1371\/journal.pone.0051044","article-title":"Arresten, a collagen-derived angiogenesis inhibitor, suppresses invasion of squamous cell carcinoma","volume":"7","author":"Aikio","year":"2012","journal-title":"PLoS ONE."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1172\/JCI24813","article-title":"Human \u03b11 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by \u03b11\u03b21 integrin","volume":"317","author":"Sudhakar","year":"2005","journal-title":"J Clin Invest."},{"key":"B27","doi-asserted-by":"publisher","first-page":"9837","DOI":"10.1158\/0008-5472.CAN-04-3536","article-title":"Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with \u03b1v\u03b23 and \u03b1v\u03b25 integrins","volume":"8","author":"Magnon","year":"2005","journal-title":"Cancer Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jphs.2018.12.001","article-title":"A current perspective of canstatin, a fragment of type IV collagen alpha 2 chain","volume":"7","author":"Okada","year":"2019","journal-title":"J Pharmacol Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1002\/cam4.866","article-title":"Recombinant canstatin inhibits VEGF-A-induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC-VII animal model","volume":"5","author":"Hwang-Bo","year":"2016","journal-title":"Cancer Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1042\/BSR20140012","article-title":"Canstatin induces apoptosis in gastric cancer xenograft growth in mice through the mitochondrial apoptotic pathway","volume":"7","author":"Xing","year":"2014","journal-title":"Biosci Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S1535-6108(03)00133-8","article-title":"Physiological levels of tumstatin, a fragment of collagen IV \u03b13 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via \u03b1V\u03b23 integrin","volume":"28","author":"Hamano","year":"2003","journal-title":"Cancer Cell."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1074\/jbc.M311901200","article-title":"\u03b1 v \u03b2 3 and \u03b1 v \u03b2 5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the \u03b13 chain of type IV collagen: Implication for the mechanism of endothelial cell adhesion","volume":"61","author":"Pedchenko","year":"2004","journal-title":"J Biol Chem"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1016\/j.bbagen.2013.12.029","article-title":"Matrikines from basement membrane collagens: a new anti-cancer strategy","volume":"1840","author":"Monboisse","year":"2014","journal-title":"Biochim Biophys Acta Gen Subj."},{"key":"B34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.matbio.2017.11.005","article-title":"Fragments generated upon extracellular matrix remodeling: Biological regulators and potential drugs","author":"Ricard-Blum","year":"2019","journal-title":"Matrix Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1074\/jbc.C000186200","article-title":"Two RGD-independent \u03b1(v)\u03b23 integrin binding sites on tumstatin regulate distinct anti-tumor properties","volume":"56","author":"Maeshima","year":"2000","journal-title":"J Biol Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1074\/jbc.M307736200","article-title":"The antitumor properties of the \u03b13(IV)-(185-203) peptide from the NC1 domain of type IV collagen (Tumstatin) are conformation-dependent","volume":"278","author":"Floquet","year":"2004","journal-title":"J Biol Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e29587","DOI":"10.1371\/journal.pone.0029587","article-title":"Tetrastatin, the NC1 domain of the \u03b14(IV) collagen chain: A novel potent anti-tumor matrikine","volume":"7","author":"Brassart-Pasco","year":"2012","journal-title":"PLoS ONE."},{"key":"B38","doi-asserted-by":"publisher","first-page":"30599","DOI":"10.1038\/s41598-018-28003-x","article-title":"Conformation-dependent binding of a Tetrastatin peptide to \u03b1v\u03b23 integrin decreases melanoma progression through FAK\/PI3K\/Akt pathway inhibition","volume":"6","author":"Lambert","year":"2018","journal-title":"Sci Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.yexcr.2004.07.036","article-title":"In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model","volume":"301","author":"Pasco","year":"2004","journal-title":"Exp Cell Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.chembiol.2006.10.007","article-title":"Structural and antitumor properties of the YSNSG cyclopeptide derived from tumstatin","volume":"13","author":"Thevenard","year":"2006","journal-title":"Chem Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.bbrc.2006.12.231","article-title":"Identification of novel short peptides derived from the \u03b14, \u03b15, and \u03b16 fibrils of type IV collagen with anti-angiogenic properties","volume":"17","author":"Karagiannis","year":"2007","journal-title":"Biochem Biophys Res Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1582-4934.2012.01648.x","article-title":"Lamstatin - a novel inhibitor of lymphangiogenesis derived from collagen IV","volume":"35","author":"Weckmann","year":"2012","journal-title":"J Cell Mol Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1186\/1471-2407-10-29","article-title":"Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model","volume":"128","author":"Koskimaki","year":"2010","journal-title":"BMC Cancer."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/ijc.23269","article-title":"Type IV collagen \u03b16 chain-derived noncollagenous domain 1 (\u03b16(IV)NC1) inhibits angiogenesis and tumor growth","volume":"122","author":"Mundel","year":"2008","journal-title":"Int J Cancer."},{"key":"B45","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1186\/s12885-017-3125-8","article-title":"Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model","volume":"588","author":"Li","year":"2017","journal-title":"BMC Cancer."},{"key":"B46","doi-asserted-by":"publisher","first-page":"75\u20136","DOI":"10.1038\/mt.2016.56","article-title":"Vastatin, an endogenous antiangiogenesis polypeptide that is lost in hepatocellular carcinoma, effectively inhibits tumor metastasis","author":"Shen","year":"2016","journal-title":"Mol Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.1006\/bbrc.1999.0248","article-title":"Antiangiogenic activity of restin, NC10 domain of human collagen XV: Comparison to endostatin","volume":"118","author":"Ramchandran","year":"1999","journal-title":"Biochem Biophys Res Commun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12943-015-0370-9","article-title":"Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a\/b expression via association with p73","volume":"62","author":"Lu","year":"2015","journal-title":"Mol Cancer."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e82730","DOI":"10.1360\/04yc0073","article-title":"Interaction of Restin with transcription factors","volume":"8","author":"Wu","year":"2005","journal-title":"Sci China Ser C Life Sci."},{"key":"B50","first-page":"5580","article-title":"Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells","volume":"62","author":"Wickstr\u00f6m","year":"2002","journal-title":"Cancer Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.bbagen.2015.09.007","article-title":"Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications","volume":"280","author":"Walia","year":"2015","journal-title":"Biochim Biophys Acta Gen Subj."},{"key":"B52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1134\/S0006297907030017","article-title":"Endostatin: current concepts about its biological role and mechanisms of action","volume":"132","author":"Digtyar","year":"2007","journal-title":"Biochem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbrc.2005.05.130","article-title":"Tumstatin, the NC1 domain of \u03b13 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth","volume":"652","author":"Hamano","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e30601","DOI":"10.1371\/journal.pone.0030601","article-title":"Inhibition of Wnt\/\u03b2-Catenin signaling by a soluble Collagen-Derived frizzled domain interacting with Wnt3a and the receptors frizzled 1 and 8","volume":"7","author":"Hendaoui","year":"2012","journal-title":"PLoS ONE."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.18632\/oncotarget.2849","article-title":"Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX","volume":"5","author":"Oudart","year":"2015","journal-title":"Oncotarget."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1010428319847081","DOI":"10.18632\/oncotarget.6399","article-title":"The anti-tumor NC1 domain of collagen XIX inhibits the FAK\/PI3K\/Akt\/mTOR signaling pathway through \u03b1v\u03b23 integrin interaction","volume":"41","author":"Oudart","year":"2016","journal-title":"Oncotarget."},{"key":"B57","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.matbio.2016.07.010","article-title":"Type XIX collagen: a new partner in the interactions between tumor cells and their microenvironment","volume":"13","author":"Oudart","year":"2017","journal-title":"Matrix Biol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"563818","DOI":"10.1016\/j.biochi.2011.10.006","article-title":"The action of neutrophil serine proteases on elastin and its precursor","volume":"2015","author":"Heinz","year":"2012","journal-title":"Biochimie."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1111\/j.1742-4658.2010.07616.x","article-title":"Degradation of tropoelastin by matrix metalloproteinases - Cleavage site specificities and release of matrikines","volume":"277","author":"Heinz","year":"2010","journal-title":"FEBS J."},{"key":"B60","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.biochi.2017.11.018","article-title":"Degradation of tropoelastin and skin elastin by neprilysin","volume":"146","author":"Mora Huertas","year":"2018","journal-title":"Biochimie."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/ijc.23296","article-title":"Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor","volume":"122","author":"Pocza","year":"2008","journal-title":"Int J Cancer."},{"key":"B62","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41416-019-0382-0","article-title":"Tumour cell blebbing and extracellular vesicle shedding: key role of matrikines and ribosomal protein SA","volume":"120","author":"Brassart","year":"2019","journal-title":"Br J Cancer."},{"key":"B63","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1242\/jcs.01613","article-title":"Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP","volume":"118","author":"Robinet","year":"2005","journal-title":"J Cell Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1046\/j.0022-202X.2004.22228.x","article-title":"Elastin-derived peptides upregulate matrix metalloproteinase-2-ediated melanoma cell invasion through elastin-binding protein","volume":"122","author":"Ntayi","year":"2004","journal-title":"J Invest Dermatol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/sj.bjc.6605926","article-title":"Elastin-derived peptides enhance melanoma growth in vivo by upregulating the activation of Mcol-A (MMP-1) collagenase","volume":"103","author":"Devy","year":"2010","journal-title":"Br J Cancer."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.biocel.2007.11.022","article-title":"Elastokine-mediated up-regulation of MT1-MMP is triggered by nitric oxide in endothelial cells","volume":"40","author":"Fahem","year":"2008","journal-title":"Int J Biochem Cell Biol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1038\/sj.jid.5700337","article-title":"Elastin fragments induce IL-1\u03b2 upregulation via NF-\u03baB pathway in melanoma cells","volume":"126","author":"Debret","year":"2006","journal-title":"J Invest Dermatol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"150","DOI":"10.4161\/cam.22827","article-title":"Laminin-111-derived peptides and cancer","volume":"7","author":"Kikkawa","year":"2013","journal-title":"Cell Adhes Migr."},{"key":"B69","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/cpr.12094","article-title":"IKVAV regulates ERK1\/2 and Akt signalling pathways in BMMSC population growth and proliferation","volume":"47","author":"Li","year":"2014","journal-title":"Cell Prolif."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1016\/j.yexcr.2011.08.022","article-title":"Laminin-111 derived peptides AG73 and C16 regulate invadopodia activity of a human adenoid cystic carcinoma cell line","volume":"317","author":"Nascimento","year":"2011","journal-title":"Exp Cell Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4161\/cam.23132","article-title":"Laminin 332 processing impacts cellular behavior","volume":"7","author":"Rousselle","year":"2013","journal-title":"Cell Adhes Migr."},{"key":"B72","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s10585-011-9422-8","article-title":"Laminin \u03b15-derived peptides modulate the properties of metastatic breast tumour cells","volume":"28","author":"Kusuma","year":"2011","journal-title":"Clin Exp Metastasis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1158\/1541-7786.MCR-08-0195","article-title":"Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling","volume":"7","author":"Ambesi","year":"2009","journal-title":"Mol Cancer Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.matbio.2009.01.003","article-title":"Regulation of p38 MAP kinase by anastellin is independent of anastellin's effect on matrix fibronectin","volume":"28","author":"You","year":"2009","journal-title":"Matrix Biol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1159\/000446244","article-title":"Prognostic value of ADAMTS proteases and their substrates in epithelial ovarian cancer","volume":"12","author":"Lima","year":"2016","journal-title":"Pathobiology."},{"key":"B76","first-page":"1022","article-title":"Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth","volume":"61","author":"Liu","year":"2001","journal-title":"Cancer Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"615","DOI":"10.18632\/oncotarget.11976","article-title":"Perlecan\/HSPG2 and matrilysin\/MMP-7 as indices of tissue invasion: Tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients","volume":"59","author":"Grindel","year":"2016","journal-title":"Oncotarget."},{"key":"B78","doi-asserted-by":"publisher","first-page":"57\u20138","DOI":"10.1016\/j.matbio.2016.09.003","article-title":"A current view of perlecan in physiology and pathology: a mosaic of functions","author":"Gubbiotti","year":"2017","journal-title":"Matrix Biol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3109\/03008207.2015.1045297","article-title":"The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy","volume":"56","author":"Douglass","year":"2015","journal-title":"Connect Tissue Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1074\/jbc.M210445200","article-title":"Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan","volume":"278","author":"Mongiat","year":"2003","journal-title":"J Biol Chem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jmb.2011.09.048","article-title":"Crystal structure of the LG3 domain of endorepellin, an angiogenesis inhibitor","volume":"414","author":"Le","year":"2011","journal-title":"J Mol Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"19245","DOI":"10.1074\/jbc.M116.740266","article-title":"Endorepellin-evoked autophagy contributes to angiostasis","volume":"291","author":"Goyal","year":"2016","journal-title":"J Biol Chem."},{"key":"B83","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.addr.2015.10.012","article-title":"Endostatin and endorepellin: a common route of action for similar angiostatic cancer avengers","volume":"97","author":"Poluzzi","year":"2016","journal-title":"Adv Drug Deliv Rev."},{"key":"B84","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.matbio.2015.10.002","article-title":"Proteoglycans regulate autophagy via outside-in signaling: an emerging new concept","volume":"48","author":"Gubbiotti","year":"2015","journal-title":"Matrix Biol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"12137","DOI":"10.1074\/jbc.RA118.002934","article-title":"Endorepellin remodels the endothelial transcriptome toward a pro-autophagic and pro-mitophagic gene signature","volume":"293","author":"Neill","year":"2018","journal-title":"J Biol Chem."},{"key":"B86","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.devcel.2009.09.008","article-title":"ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression","volume":"17","author":"McCulloch","year":"2009","journal-title":"Dev Cell."},{"key":"B87","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.matbio.2014.01.005","article-title":"The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis","volume":"35","author":"Nandadasa","year":"2014","journal-title":"Matrix Biol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1182\/blood-2016-03-705780","article-title":"Immunoregulatory roles of versican proteolysis in the myeloma microenvironment","volume":"128","author":"Hope","year":"2016","journal-title":"Blood."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1016\/j.yexcr.2010.08.002","article-title":"Lumican inhibits cell migration through \u03b12?1 integrin","volume":"316","author":"Zeltz","year":"2010","journal-title":"Exp Cell Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1016\/j.febslet.2014.09.040","article-title":"Lumican: a new inhibitor of matrix metalloproteinase-14 activity","volume":"588","author":"Pietraszek","year":"2014","journal-title":"FEBS Lett."},{"key":"B91","doi-asserted-by":"publisher","first-page":"75\u20136","DOI":"10.1016\/j.matbio.2017.12.006","article-title":"Small leucine-rich proteoglycans and matrix metalloproteinase-14: key partners?","author":"Pietraszek-Gremplewicz","year":"2019","journal-title":"Matrix Biol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e1238542","DOI":"10.1038\/srep42057","article-title":"Lumican peptides: rational design targeting ALK5\/TGFBRI","volume":"5","author":"Gesteira","year":"2017","journal-title":"Sci Rep."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1111\/febs.12210","article-title":"Lumican effects in the control of tumour progression and their links with metalloproteinases and integrins","volume":"280","author":"Br\u00e9zillon","year":"2013","journal-title":"FEBS J."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e76232","DOI":"10.1371\/journal.pone.0076232","article-title":"Lumican - derived peptides inhibit melanoma cell growth and migration","volume":"8","author":"Pietraszek","year":"2013","journal-title":"PLoS ONE."},{"key":"B95","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.1021\/acs.chemrev.8b00354","article-title":"Proteoglycan chemical diversity drives multifunctional cell regulation and therapeutics","volume":"118","author":"Karamanos","year":"2018","journal-title":"Chem Rev."},{"key":"B96","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.semcancer.2019.08.003","article-title":"Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator","volume":"62","author":"Karamanou","year":"2019","journal-title":"Semin Cancer Biol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.febslet.2009.08.012","article-title":"Lumcorin: a leucine-rich repeat 9-derived peptide from human lumican inhibiting melanoma cell migration","volume":"62","author":"Zeltz","year":"2009","journal-title":"FEBS Lett."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e82730","DOI":"10.1371\/journal.pone.0082730","article-title":"Lumican binds ALK5 to promote epithelium wound healing","volume":"8","author":"Yamanaka","year":"2013","journal-title":"PLoS ONE."},{"key":"B99","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1371\/journal.pone.0217550","article-title":"The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4+ T cell polarization in inflammatory and non-inflammatory breast cancer patients","volume":"18","author":"Saleh","year":"2019","journal-title":"PLoS ONE."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1111\/febs.12160","article-title":"Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-\u03b1v\u03b23 integrin complex in tumorigenesis and angiogenesis","volume":"280","author":"Rapraeger","year":"2013","journal-title":"FEBS J."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1111\/febs.12134","article-title":"Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between \u03b1v\u03b23 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis","volume":"280","author":"Rapraeger","year":"2013","journal-title":"FEBS J."},{"key":"B102","doi-asserted-by":"publisher","first-page":"jcs232645","DOI":"10.1242\/jcs.232645","article-title":"VLA-4 phosphorylation during tumor and immune cell migration relies on its coupling to VEGFR2 and CXCR4 by syndecan-1","volume":"132","author":"Jung","year":"2019","journal-title":"J Cell Sci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.abb.2018.06.007","article-title":"Inhibition of the signaling pathway of syndecan-1 by synstatin: a promising anti-integrin inhibitor of angiogenesis and proliferation in HCC in rats","volume":"652","author":"Metwaly","year":"2018","journal-title":"Arch Biochem Biophys."},{"key":"B104","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1074\/jbc.M115.679084","article-title":"Syndecan-1 and syndecan-4 capture epidermal growth factor receptor family members and the \u03b13\u03b21 integrin via binding sites in their ectodomains: novel synstatins prevent kinase capture and inhibit\u03b16\u03b24-integrindependent epithelial cell motility","volume":"18","author":"Wang","year":"2015","journal-title":"J Biol Chem."},{"key":"B105","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1084\/jem.20081278","article-title":"Syndecan-1 regulates \u03b1 v\u03b2 3 and \u03b1 v\u03b2 5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor","volume":"206","author":"Beauvais","year":"2009","journal-title":"J Exp Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1038\/oncsis.2016.5","article-title":"Heparanase-induced shedding of syndecan-1\/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins","volume":"5","author":"Jung","year":"2016","journal-title":"Oncogenesis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"57\u20138","DOI":"10.3389\/fonc.2019.00248","article-title":"Next-generation cancer immunotherapy targeting glypican-3","author":"Shimizu","year":"2019","journal-title":"Front Oncol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/med.21455","article-title":"Glypican-3: a promising biomarker for hepatocellular carcinoma diagnosis and treatment","volume":"13","author":"Zhou","year":"2018","journal-title":"Med Res Rev."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/hep.30646","article-title":"A frizzled-like cysteine-rich domain in glypican-3 mediates Wnt binding and regulates hepatocellular carcinoma tumor growth in mice","volume":"70","author":"Li","year":"2019","journal-title":"Hepatology."},{"key":"B110","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3389\/fonc.2019.00708","article-title":"The role of glypican-3 in regulating Wnt, YAP, and Hedgehog in liver cancer","volume":"9","author":"Kolluri","year":"2019","journal-title":"Front Oncol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"43094","DOI":"10.1074\/jbc.M112.349209","article-title":"The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering","volume":"287","author":"Yang","year":"2012","journal-title":"J Biol Chem."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1111\/cas.12913","article-title":"Role of hyaluronan in pancreatic cancer biology and therapy: once again in the spotlight","volume":"277","author":"Sato","year":"2016","journal-title":"Cancer Sci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2174\/1568009611313040001","article-title":"Aberrant splicing, Hyaluronan synthases and intracellular Hyaluronan as drivers of oncogenesis and potential drug targets","volume":"13","author":"Adamia","year":"2013","journal-title":"Curr Cancer Drug Targets."},{"key":"B114","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.matbio.2016.10.001","article-title":"Roles and targeting of the HAS\/hyaluronan\/CD44 molecular system in cancer","volume":"94","author":"Karousou","year":"2017","journal-title":"Matrix Biol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"e0187860","DOI":"10.1038\/srep30599","article-title":"Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients","volume":"12","author":"Kehlet","year":"2016","journal-title":"Sci Rep."},{"key":"B116","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.cca.2013.09.011","article-title":"Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients","volume":"436","author":"Tang","year":"2013","journal-title":"Clin Chim Acta."},{"key":"B117","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/cncr.10267","article-title":"Serum cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as a prognostic tumor marker in patients with esophageal squamous cell carcinoma","volume":"94","author":"Nabeya","year":"2002","journal-title":"Cancer."},{"key":"B118","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/1010428319847081","article-title":"Elevated preoperative serum levels of collagen I carboxyterminal telopeptide predict better outcome in early-stage luminal-B-like (HER2-negative) and triple-negative subtypes of breast cancer","volume":"13","author":"J\u00e4\u00e4skel\u00e4inen","year":"2019","journal-title":"Tumor Biol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1371\/journal.pone.0187860","article-title":"Elevated N-telopeptide as a potential diagnostic marker for bone metastasis in lung cancer: A meta-analysis","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS ONE."},{"key":"B120","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cca.2014.06.025","article-title":"Serum crosslinked-N-terminal telopeptide of type I collagen (NTx) has prognostic implications for patients with initial prostate carcinoma (PCa): A pilot study","volume":"18","author":"Jablonka","year":"2014","journal-title":"Clin Chim Acta."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.cllc.2012.03.012","article-title":"Clinical significance of the serum crosslinked N-telopeptide of type i collagen as a prognostic marker for non-small-cell lung cancer","volume":"111","author":"Tamiya","year":"2013","journal-title":"Clin Lung Cancer."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1299::AID-CNCR5>3.0.CO;2-C","article-title":"N-terminal peptide of type III procollagen: a possible predictor of colorectal carcinoma recurrence","volume":"79","author":"Plebani","year":"1997","journal-title":"Cancer."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1016\/j.tranon.2018.02.005","article-title":"Tumstatin, a matrikine derived from collagen type IV\u03b13, is elevated in serum from patients with non-small cell lung cancer","volume":"130","author":"Nielsen","year":"2018","journal-title":"Transl Oncol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1186\/1471-2407-13-554","article-title":"Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls","volume":"97","author":"Willumsen","year":"2013","journal-title":"BMC Cancer."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.tranon.2019.02.004","article-title":"Matrix metalloprotease generated fragments of type VI collagen have serum biomarker potential in cancer - a proof of concept study","volume":"63","author":"Willumsen","year":"2019","journal-title":"Transl Oncol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s11605-013-2326-y","article-title":"Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma","volume":"59","author":"Kang","year":"2014","journal-title":"J Gastrointest Surg."},{"key":"B127","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/bjc.2014.456","article-title":"Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers","volume":"65","author":"Kantola","year":"2014","journal-title":"Br J Cancer."},{"key":"B128","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/1097-0142(20010415)91:8<1525::AID-CNCR1161>3.0.CO;2-P","article-title":"Serum endostatin levels are elevated in patients with soft tissue sarcoma","volume":"65","author":"Feldman","year":"2001","journal-title":"Cancer."},{"key":"B129","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.clon.2012.11.009","article-title":"Elevated serum endostatin levels are associated with poor survival in patients with advanced-stage nasopharyngeal carcinoma","volume":"25","author":"Mo","year":"2013","journal-title":"Clin Oncol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1179\/102453308X315898","article-title":"Elevated serum endostatin levels are associated with favorable outcome in acute myeloid leukemia","volume":"2","author":"Aref","year":"2008","journal-title":"Hematology."},{"key":"B131","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/ijc.26343","article-title":"Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer","volume":"35","author":"Szarvas","year":"2012","journal-title":"Int J Cancer."},{"key":"B132","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/cncr.11399","article-title":"Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma","volume":"15","author":"Bono","year":"2003","journal-title":"Cancer."},{"key":"B133","doi-asserted-by":"publisher","first-page":"878","DOI":"10.7754\/Clin.Lab.2017.170217","article-title":"Diagnostic values of sVEGFR-1 and endostatin in malignant pleural effusions in patients with lung cancer","volume":"37","author":"Zhu","year":"2017","journal-title":"Clin Lab."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.5754\/hge10602","article-title":"Correlations between serum levels of vascular endothelial growth factor and endostatin with clinical pathological characteristics of patients with gastrointestinal cancers","volume":"59","author":"Li","year":"2012","journal-title":"Hepatogastroenterology."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s00432-018-2799-x","article-title":"Non-invasive profiling of protease-specific elastin turnover in lung cancer: biomarker potential","volume":"199","author":"Thorlacius-Ussing","year":"2019","journal-title":"J Cancer Res Clin Oncol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1002\/hed.20838","article-title":"Serum concentrations of laminin \u03b32 fragments in patients with head and neck squamous cell carcinoma","volume":"583","author":"Kuratomi","year":"2008","journal-title":"Head Neck."},{"key":"B137","doi-asserted-by":"publisher","first-page":"42057","DOI":"10.1038\/bjc.1992.105","article-title":"Urinary laminin fragments as a tumour marker potentially reflecting basement membrane destruction","volume":"7","author":"Katayama","year":"1992","journal-title":"Br J Cancer."},{"key":"B138","doi-asserted-by":"publisher","first-page":"e0217550","DOI":"10.1038\/bjc.1992.123","article-title":"Serum laminin P1 in small cell lung cancer: a valuable indicator of distant metastasis?","volume":"14","author":"Nakano","year":"1992","journal-title":"Br J Cancer."},{"key":"B139","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1159\/000282545","article-title":"Urine laminin p1 assessment discriminates between invasive and noninvasive urothelial cell carcinoma of the bladder","volume":"12","author":"Abou Farha","year":"1993","journal-title":"Urol Int."},{"key":"B140","doi-asserted-by":"publisher","first-page":"26103","DOI":"10.1002\/prca.200780049","article-title":"Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer","volume":"290","author":"Chang","year":"2008","journal-title":"Proteomics Clin Appl."},{"key":"B141","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10719-018-9815-x","article-title":"Biomolecular analysis of matrix proteoglycans as biomarkers in non small cell lung cancer","volume":"35","author":"Rangel","year":"2018","journal-title":"Glycoconj J."},{"key":"B142","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1021\/acs.jproteome.5b00420","article-title":"Quantitative tissue proteomics analysis reveals versican as potential biomarker for early-stage hepatocellular carcinoma","volume":"4","author":"Naboulsi","year":"2016","journal-title":"J Proteome Res."},{"key":"B143","doi-asserted-by":"publisher","first-page":"19006","DOI":"10.1093\/carcin\/bgw069","article-title":"Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer","volume":"9","author":"Chida","year":"2016","journal-title":"Carcinogenesis."},{"key":"B144","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/ijgc-2019-ESGO.197","article-title":"Discovery and validation of novel biomarkers for detection of epithelial ovarian cancer","volume":"21","author":"Kulbe","year":"2019","journal-title":"Cells."},{"key":"B145","doi-asserted-by":"publisher","first-page":"741","DOI":"10.4049\/jimmunol.1700529","article-title":"Versican-derived matrikines regulate Batf3-dendritic cell differentiation and promote T cell infiltration in colorectal cancer","volume":"38","author":"Hope","year":"2017","journal-title":"J Immunol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"e1129483","DOI":"10.5009\/gnl18286","article-title":"Syndecan-2 methylation as a new biomarker for early detection of colorectal neoplasm","volume":"5","author":"Kim","year":"2018","journal-title":"Gut Liver."},{"key":"B147","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5009\/gnl17357","article-title":"Analysis of syndecan-2 methylation in bowel lavage fluid for the detection of colorectal neoplasm","volume":"10","author":"Park","year":"2018","journal-title":"Gut Liver."},{"key":"B148","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1369\/0022155411405057","article-title":"Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma","volume":"107","author":"Lendorf","year":"2011","journal-title":"J Histochem Cytochem."},{"key":"B149","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature14581","article-title":"Glypican-1 identifies cancer exosomes and detects early pancreatic cancer","volume":"523","author":"Melo","year":"2015","journal-title":"Nature."},{"key":"B150","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3978\/j.issn.2305-5839.2015.10.39","article-title":"Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer","volume":"55","author":"Herreros-Villanueva","year":"2016","journal-title":"Ann Transl Med."},{"key":"B151","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.canlet.2017.02.019","article-title":"A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer","volume":"81","author":"Lai","year":"2017","journal-title":"Cancer Lett."},{"key":"B152","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s13046-018-0911-3","article-title":"Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1\/JAK2\/STAT3 signaling pathway","volume":"17","author":"Zhou","year":"2018","journal-title":"J Exp Clin Cancer Res."},{"key":"B153","doi-asserted-by":"publisher","first-page":"59","DOI":"10.18632\/oncotarget.24873","article-title":"Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden","volume":"139","author":"Frampton","year":"2018","journal-title":"Oncotarget."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/cam4.1064","article-title":"Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma","volume":"6","author":"Lu","year":"2017","journal-title":"Cancer Med."},{"key":"B155","doi-asserted-by":"publisher","first-page":"101189","DOI":"10.18632\/oncotarget.20516","article-title":"The clinical significance of circulating GPC1 positive exosomes and its regulative miRNAs in colon cancer patients","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget."},{"key":"B156","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/jcmm.12941","article-title":"GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer","volume":"21","author":"Li","year":"2017","journal-title":"J Cell Mol Med."},{"key":"B157","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3892\/ijo.2013.1793","article-title":"Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide","volume":"42","author":"Iwama","year":"2013","journal-title":"Int J Oncol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s00262-012-1366-6","article-title":"Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: A potential option for improvement in antigen-specific cancer immunotherapy","volume":"17","author":"Nobuoka","year":"2013","journal-title":"Cancer Immunol Immunother."},{"key":"B159","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/2162402X.2016.1238542","article-title":"Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma","volume":"14","author":"Suzuki","year":"2016","journal-title":"Oncoimmunology."},{"key":"B160","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1158\/1078-0432.CCR-11-3044","article-title":"Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: Immunologic evidence and potential for improving overall survival","volume":"48","author":"Sawada","year":"2012","journal-title":"Clin Cancer Res."},{"key":"B161","doi-asserted-by":"publisher","first-page":"e1129483","DOI":"10.1080\/2162402X.2015.1129483","article-title":"Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients","volume":"5","author":"Sawada","year":"2016","journal-title":"Oncoimmunology."},{"key":"B162","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.5582\/bst.2015.01128","article-title":"Status of and prospects for cancer vaccines against hepatocellular carcinoma in clinical trials","volume":"6","author":"Sun","year":"2016","journal-title":"Biosci Trends."},{"key":"B163","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12931-017-0546-5","article-title":"CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives","volume":"18","author":"Cortes-Dericks","year":"2017","journal-title":"Respir Res."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1038\/s41598-018-33337-7","article-title":"Hyaluronic acid-CD44 interactions promote BMP4\/7-dependent Id1\/3 expression in melanoma cells","volume":"122","author":"Wu","year":"2018","journal-title":"Sci Rep."},{"key":"B165","doi-asserted-by":"publisher","first-page":"563818","DOI":"10.1155\/2015\/563818","article-title":"Size matters: molecular weight specificity of hyaluronan effects in cell biology","volume":"2015","author":"Cyphert","year":"2015","journal-title":"Int J Cell Biol."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00397\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:43:04Z","timestamp":1586911384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00397\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":165,"alternative-id":["10.3389\/fonc.2020.00397"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00397","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,15]]},"article-number":"397"}}